ASX - By Stock
|
MSB |
Re:
Ann: FDA Notifies Clinical Data Sufficient for Refiling aGVHD BLA
|
|
AllanHU
|
1.0K |
416K |
5 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
1.0K
|
416K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
AllanHU
|
226 |
81K |
3 |
26/03/24 |
26/03/24 |
ASX - By Stock
|
226
|
81K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Completes Institutional Allocation
|
|
AllanHU
|
263 |
69K |
2 |
08/12/23 |
08/12/23 |
ASX - By Stock
|
263
|
69K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Change in substantial holding
|
|
AllanHU
|
88 |
28K |
25 |
09/08/23 |
09/08/23 |
ASX - By Stock
|
88
|
28K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Ann: FDA Accepts Mesoblast's BLA Resubmission for Remestemcel-L
|
|
AllanHU
|
1.0K |
391K |
12 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
1.0K
|
391K
|
12
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
AllanHU
|
74 |
28K |
11 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
11
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Pause in Trading
|
|
AllanHU
|
74 |
28K |
10 |
08/03/23 |
08/03/23 |
ASX - By Stock
|
74
|
28K
|
10
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Banter and General Comments
|
|
AllanHU
|
11K |
6.0M |
0 |
27/02/23 |
27/02/23 |
ASX - By Stock
|
11K
|
6.0M
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: PolyNovo enters India market
|
|
AllanHU
|
321 |
92K |
6 |
07/11/22 |
07/11/22 |
ASX - By Stock
|
321
|
92K
|
6
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Becoming a substantial holder
|
|
AllanHU
|
84 |
31K |
0 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
84
|
31K
|
0
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Becoming a substantial holder
|
|
AllanHU
|
84 |
31K |
3 |
21/09/22 |
21/09/22 |
ASX - By Stock
|
84
|
31K
|
3
|
|
ASX - By Stock
|
PNV |
Re:
Ann: FY22 Results Webcast details
|
|
AllanHU
|
108 |
33K |
5 |
17/08/22 |
17/08/22 |
ASX - By Stock
|
108
|
33K
|
5
|
|
ASX - By Stock
|
MSB Biotech |
Re:
Why are PNV holders frequenting MSB?
|
|
AllanHU
|
13 |
5.2K |
20 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
13
|
5.2K
|
20
|
|
ASX - By Stock
|
MSB Biotech |
Re:
Why are PNV holders frequenting MSB?
|
|
AllanHU
|
13 |
5.2K |
12 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
13
|
5.2K
|
12
|
|
ASX - By Stock
|
MSB Biotech |
Re:
Why are PNV holders frequenting MSB?
|
|
AllanHU
|
13 |
5.2K |
4 |
10/08/22 |
10/08/22 |
ASX - By Stock
|
13
|
5.2K
|
4
|
|
ASX - By Stock
|
MSB Biotech |
Why are PNV holders frequenting MSB?
|
|
AllanHU
|
13 |
5.2K |
15 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
13
|
5.2K
|
15
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
AllanHU
|
17K |
6.7M |
3 |
09/08/22 |
09/08/22 |
ASX - By Stock
|
17K
|
6.7M
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Cell Therapy News/Articles
|
|
AllanHU
|
17K |
6.7M |
6 |
08/08/22 |
08/08/22 |
ASX - By Stock
|
17K
|
6.7M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
AllanHU
|
256 |
108K |
1 |
07/08/22 |
07/08/22 |
ASX - By Stock
|
256
|
108K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Trading Halt
|
|
AllanHU
|
256 |
108K |
25 |
07/08/22 |
07/08/22 |
ASX - By Stock
|
256
|
108K
|
25
|
|
ASX - By Stock
|
MSB |
Re:
Capital raising
|
|
AllanHU
|
197 |
71K |
8 |
06/08/22 |
06/08/22 |
ASX - By Stock
|
197
|
71K
|
8
|
|
ASX - By Stock
|
MSB |
Re:
So what huge parnter is expected
|
|
AllanHU
|
25 |
9.8K |
3 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
25
|
9.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
So what huge parnter is expected
|
|
AllanHU
|
25 |
9.8K |
18 |
05/08/22 |
05/08/22 |
ASX - By Stock
|
25
|
9.8K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
So what huge parnter is expected
|
|
AllanHU
|
25 |
9.8K |
4 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
25
|
9.8K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
So what huge parnter is expected
|
|
AllanHU
|
25 |
9.8K |
3 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
25
|
9.8K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
So what huge parnter is expected
|
|
AllanHU
|
25 |
9.8K |
18 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
25
|
9.8K
|
18
|
|
ASX - By Stock
|
MSB |
Re:
So what huge parnter is expected
|
|
AllanHU
|
25 |
9.8K |
5 |
04/08/22 |
04/08/22 |
ASX - By Stock
|
25
|
9.8K
|
5
|
|
ASX - By Stock
|
PNV |
Re:
30th June 2023 Share Price Prediction
|
|
AllanHU
|
118 |
39K |
1 |
01/08/22 |
01/08/22 |
ASX - By Stock
|
118
|
39K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
AllanHU
|
129 |
44K |
3 |
30/07/22 |
30/07/22 |
ASX - By Stock
|
129
|
44K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
AllanHU
|
129 |
44K |
6 |
30/07/22 |
30/07/22 |
ASX - By Stock
|
129
|
44K
|
6
|
|
ASX - By Stock
|
PNV |
Re:
PNV - Chart
|
|
AllanHU
|
19K |
11M |
2 |
18/07/22 |
18/07/22 |
ASX - By Stock
|
19K
|
11M
|
2
|
|
ASX - By Stock
|
PNV |
Re:
Ann: Director Share Purchase - David Williams
|
|
AllanHU
|
81 |
24K |
3 |
18/05/22 |
18/05/22 |
ASX - By Stock
|
81
|
24K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
3 |
14/09/21 |
14/09/21 |
ASX - By Stock
|
97
|
249K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
4 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
97
|
249K
|
4
|
|
ASX - By Stock
|
PNV |
Re:
US Chronic wound reimbursement study update and October BTM smaller size launch
|
|
AllanHU
|
14 |
5.3K |
17 |
13/09/21 |
13/09/21 |
ASX - By Stock
|
14
|
5.3K
|
17
|
|
ASX - By Stock
|
MSB |
Re:
FY22 - It's all to play for here!
|
|
AllanHU
|
145 |
41K |
2 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
145
|
41K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
FY22 - It's all to play for here!
|
|
AllanHU
|
145 |
41K |
1 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
145
|
41K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FY22 - It's all to play for here!
|
|
AllanHU
|
145 |
41K |
2 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
145
|
41K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Ann: MSB Annual Financial Results and Operational Progress
|
|
AllanHU
|
206 |
62K |
1 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
206
|
62K
|
1
|
|
ASX - By Stock
|
MSB |
Re:
FY22 - It's all to play for here!
|
|
AllanHU
|
145 |
41K |
3 |
03/09/21 |
03/09/21 |
ASX - By Stock
|
145
|
41K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
MSB Vs PNV who will gain the most in 2020?
|
|
AllanHU
|
97 |
249K |
3 |
09/02/21 |
09/02/21 |
ASX - By Stock
|
97
|
249K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Phase 3 Chronic Heart Failure Results
|
|
AllanHU
|
1.0K |
418K |
5 |
22/12/20 |
22/12/20 |
ASX - By Stock
|
1.0K
|
418K
|
5
|
|
ASX - By Stock
|
MSB |
Re:
MSB Trading 2020 - a new dawn
|
|
AllanHU
|
13K |
5.0M |
6 |
20/12/20 |
20/12/20 |
ASX - By Stock
|
13K
|
5.0M
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Novartis deal on the rocks
|
|
AllanHU
|
247 |
89K |
3 |
20/12/20 |
20/12/20 |
ASX - By Stock
|
247
|
89K
|
3
|
|
ASX - By Stock
|
MSB |
Re:
Novartis deal on the rocks
|
|
AllanHU
|
247 |
89K |
4 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
247
|
89K
|
4
|
|
ASX - By Stock
|
MSB |
Re:
Novartis deal on the rocks
|
|
AllanHU
|
247 |
89K |
6 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
247
|
89K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Novartis deal on the rocks
|
|
AllanHU
|
247 |
89K |
6 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
247
|
89K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Novartis deal on the rocks
|
|
AllanHU
|
247 |
89K |
2 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
247
|
89K
|
2
|
|
ASX - By Stock
|
MSB |
Re:
Novartis deal on the rocks
|
|
AllanHU
|
247 |
89K |
6 |
19/12/20 |
19/12/20 |
ASX - By Stock
|
247
|
89K
|
6
|
|
ASX - By Stock
|
MSB |
Re:
Ann: Mesoblast Update on COVID-19 ARDS Trial
|
|
AllanHU
|
1.0K |
517K |
1 |
18/12/20 |
18/12/20 |
ASX - By Stock
|
1.0K
|
517K
|
1
|
|